TY  - GEN
AU  - Scholz,M
AU  - Engert,A
AU  - Franklin,J
AU  - Josting,A
AU  - Diehl,V
AU  - Hasenclever,D
AU  - Loeffler,M
TI  - Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis
SN  - 1569-8041
PY  - 2011///0614
KW  - Algorithms
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bleomycin
KW  - Cyclophosphamide
KW  - Dacarbazine
KW  - Doxorubicin
KW  - Etoposide
KW  - Glyoxal
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Ifosfamide
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Myeloid, Acute
KW  - chemically induced
KW  - Lymphoma, Non-Hodgkin
KW  - Myelodysplastic Syndromes
KW  - Neoplasms, Second Primary
KW  - Prednimustine
KW  - Prednisone
KW  - Procarbazine
KW  - Proportional Hazards Models
KW  - Randomized Controlled Trials as Topic
KW  - Risk Assessment
KW  - Treatment Outcome
KW  - Vinblastine
KW  - Vincristine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdq408
ER  -